B2M and diffuse large B-cell lymphoma: Of the 126 evaluable cases 35 (28%) were completely negative for B2M while 29 patients (23%) showed cytoplasmic expression of B2M, so a loss of membrane B2M expression was observed in a total of 51% of the DLBCL cases.